Orexigen claims success in weight-loss trial - FierceBiotech - Biotechnology Articles, Biotech Industry News, FDA Approval News

Orexigen claims success in weight-loss trial - FierceBiotech - Biotechnology Articles, Biotech Industry News, FDA Approval News: "Orexigen Therapeutics says that a mid-stage trial of its weight-loss drug generated a statistically significant response compared to placebos. The study involving 620 patients concluded that the group taking its zonisamide-based formulation experienced an average 8.6 percent reduction in weight compared to a 1.1 percent drop in weight for the placebo group. Its shares were buoyed by the news."